Wheeler Bio

Wheeler Bio is a disruptive new biopharmaceutical CDMO that brings biologics drug innovators, discovery CROs, and CDMOs together to solve an outdated industry bottleneck with a unique partnering model, built on shared success and lasting collaborations. The typical momentum drop between discovery and development poses significant challenges for emerging biopharma companies adding technical, financial, and regulatory risks. We believe these lifecycle challenges can be reduced with more democratization of manufacturing platforms. Wheeler's pioneering open-source development platform, Portable CMC™, delivers speed, efficiency, predictability, and freedom by integrating discovery CROs and CDMOs. Wheeler is proud to currently offer best-in class mammalian cell line development, GLP material supply, and an efficient path to GMP.